UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000004507 |
|---|---|
| Receipt number | R000005388 |
| Scientific Title | Pharmacogenomic analysis for Phase II clinical trial of the third-line Cetuximab and irinotecan or Cetuximab therapy for patients with KRAS wild type unresectable/recurrent colorectal cancer |
| Date of disclosure of the study information | 2010/11/08 |
| Last modified on | 2018/10/31 22:39:11 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2010/11/05 11:48:00 | ||
| 2 | Update | 2011/09/18 06:59:40 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 3 | Update | 2011/09/18 06:59:58 | Recruitment status |
|
| 4 | Update | 2011/11/05 16:08:40 | Recruitment status |
|
| 5 | Update | 2012/05/07 10:18:29 | Recruitment status Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 6 | Update | 2012/09/17 06:40:58 | Recruitment status |
|
| 7 | Update | 2018/10/31 22:39:11 | Last name of lead principal investigator Last name of lead principal investigator TEL Last name of contact person Last name of contact person Address Address TEL Name of primary person or sponsor Organization Category of Funding Organization |
